BIRC5 and esophageal cancer: By combining the presence of RNAm of CEA and of Survivin (member of the apoptosis inhibitors’ family), revealed by RT-PCR in blood samples from patients with esophagus cancer after surgery, Liu Z. and al [29] proved that it could predict the risk of developing micrometastasis.